{"product_id":"university-of-miami-management-of-alcohol-substance-use-disorders-2025","title":"University of Miami Management of Alcohol \u0026 Substance Use Disorders 2025","description":"\u003cdiv class=\"prod-edition\"\u003e\r\n\u003cdiv class=\"field field--name-field-heading field--type-heading field--label-hidden field__item\"\u003e\r\n\u003cdiv class=\"columns small-12 medium-12 large-12 sidebar-full\"\u003e\r\n\u003cdiv\u003e\r\n\u003ch1 class=\"product-title product_title entry-title\"\u003eUniversity of Miami Management of Alcohol \u0026amp; Substance Use Disorders 2025\u003c\/h1\u003e\r\n\u003c\/div\u003e\r\n\u003cdiv class=\"activitysectionbold\"\u003eONly Videos no PDFs\u003c\/div\u003e\r\n\u003cdiv\u003e\r\n\u003cdiv class=\"activitysectionbold\"\u003eOverview\u003c\/div\u003e\r\n\u003cul\u003e\r\n \t\u003cli\u003eSubstance use disorders are common in both general psychiatric, other mental health, and medical practice. Because clinicians often do not have the knowledge about how to treat these disorders, it is common for clinicians to not screen for them. This often leads to poor outcomes for these patients. This course will review key issues that clinicians need to know about the diagnosis and treatment of patients with alcohol and drug use problems. The course will consist of lecture and frequent audience interaction, including discussion of cases. The course will review diagnosis, pharmacologic and behavioral treatment strategies, treatment of patients with co-occurring psychiatric illness, a review of the common drugs of misuse, including prescription drug misuse, recent drug trends (e.g., the opioid overdose epidemic, the legalization of cannabis for medical and recreational use), and strategies to help family members of those with substance use disorders.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cdiv class=\"activitysectionbold\"\u003eACCME Objectives\u003c\/div\u003e\r\n\u003col\u003e\r\n \t\u003cli\u003eDiagnose substance use disorders.\u003c\/li\u003e\r\n \t\u003cli\u003eDetermine options for abstinence vs. cutting down.\u003c\/li\u003e\r\n \t\u003cli\u003eEvaluate indications for and use of common substance use disorder medications.\u003c\/li\u003e\r\n \t\u003cli\u003eDistinguish substance-induced disorders vs. independent psychiatric illness.\u003c\/li\u003e\r\n \t\u003cli\u003eRefer patients knowledgeably to mutual-help groups such as AA or SMART Recovery.\u003c\/li\u003e\r\n \t\u003cli\u003eEvaluate key properties of the common drugs of misuse.\u003c\/li\u003e\r\n \t\u003cli\u003eDevelop helpful strategies for family members of those with substance use disorders.\u003c\/li\u003e\r\n \t\u003cli\u003eDevelop helpful strategies for patients who want to cut down but whom you think should abstain.\u003c\/li\u003e\r\n \t\u003cli\u003eAnalyze models of both psychopharmacological and psychotherapeutic treatments for patients with substance use disorders and co-occurring psychiatric illness.\u003c\/li\u003e\r\n\u003c\/ol\u003e\r\n\u003cdiv class=\"activitysectionbold\"\u003eAPA Objectives\u003c\/div\u003e\r\n\u003col\u003e\r\n \t\u003cli\u003eDiagnose substance use disorders.\u003c\/li\u003e\r\n \t\u003cli\u003eDetermine options for abstinence vs. cutting down.\u003c\/li\u003e\r\n \t\u003cli\u003eEvaluate indications for and use of common substance use disorder medications.\u003c\/li\u003e\r\n \t\u003cli\u003eDistinguish substance-induced disorders vs. independent psychiatric illness.\u003c\/li\u003e\r\n \t\u003cli\u003eRefer patients knowledgeably to mutual-help groups such as AA or SMART Recovery.\u003c\/li\u003e\r\n \t\u003cli\u003eEvaluate key properties of the common drugs of misuse.\u003c\/li\u003e\r\n \t\u003cli\u003eDevelop helpful strategies for family members of those with substance use disorders.\u003c\/li\u003e\r\n \t\u003cli\u003eDevelop helpful strategies for patients who want to cut down but whom you think should abstain.\u003c\/li\u003e\r\n \t\u003cli\u003eAnalyze models of both psychopharmacological and psychotherapeutic treatments for patients with substance use disorders and co-occurring psychiatric illness.\u003c\/li\u003e\r\n\u003c\/ol\u003e\r\n\u003c\/div\u003e\r\n\u003cdiv\u003e\u003c\/div\u003e\r\n\u003cdiv\u003e\u003c\/div\u003e\r\n\u003cdiv\u003e\u003c\/div\u003e\r\n\u003cdiv\u003e\r\n\u003ctable\u003e\r\n\u003cthead\u003e\r\n\u003ctr\u003e\r\n\u003cth\u003eSr No\u003c\/th\u003e\r\n\u003cth\u003eTitle\u003c\/th\u003e\r\n\u003cth\u003eTime\u003c\/th\u003e\r\n\u003c\/tr\u003e\r\n\u003c\/thead\u003e\r\n\u003ctbody\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e1\u003c\/td\u003e\r\n\u003ctd\u003eHow Substances Impact Psychiatric Diagnoses: Cannabis \u0026amp; Alcohol\u003c\/td\u003e\r\n\u003ctd\u003e11:20\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e2\u003c\/td\u003e\r\n\u003ctd\u003eTreating Comorbid Mood \u0026amp; Substance Disorder: Medications\u003c\/td\u003e\r\n\u003ctd\u003e24:28\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e3\u003c\/td\u003e\r\n\u003ctd\u003eTreating Comorbid Mood \u0026amp; Substance Disorder: Psychotherapy\u003c\/td\u003e\r\n\u003ctd\u003e28:09\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e4\u003c\/td\u003e\r\n\u003ctd\u003eMedications for Opioid Use Disorder \u0026amp; How They Compare\u003c\/td\u003e\r\n\u003ctd\u003e44:02\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e5\u003c\/td\u003e\r\n\u003ctd\u003eThe Myth of the Dual Diagnosis Patient\u003c\/td\u003e\r\n\u003ctd\u003e24:35\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e6\u003c\/td\u003e\r\n\u003ctd\u003ePsychosocial Treatments for SUD: CBT, MET \u0026amp; CM\u003c\/td\u003e\r\n\u003ctd\u003e36:22\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e7\u003c\/td\u003e\r\n\u003ctd\u003eUnderstanding Controlled Drinking: Tolerance, Risk, and the Road to Abstinence\u003c\/td\u003e\r\n\u003ctd\u003e27:07\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e8\u003c\/td\u003e\r\n\u003ctd\u003eMotivating the Unmotivated Patient with Substance Use Disorder\u003c\/td\u003e\r\n\u003ctd\u003e30:48\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e9\u003c\/td\u003e\r\n\u003ctd\u003ePrescription Stimulant Misuse: Overview \u0026amp; Treatment\u003c\/td\u003e\r\n\u003ctd\u003e13:51\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e10\u003c\/td\u003e\r\n\u003ctd\u003eCocaine Use Disorder: Overview \u0026amp; Treatment\u003c\/td\u003e\r\n\u003ctd\u003e19:06\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e11\u003c\/td\u003e\r\n\u003ctd\u003eMethamphetamine Use Disorder: Overview \u0026amp; Treatment\u003c\/td\u003e\r\n\u003ctd\u003e24:10\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e12\u003c\/td\u003e\r\n\u003ctd\u003eNovel Illicit Psychoactive Substances\u003c\/td\u003e\r\n\u003ctd\u003e10:41\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e13\u003c\/td\u003e\r\n\u003ctd\u003eHallucinogens: Different Types \u0026amp; How to Treat\u003c\/td\u003e\r\n\u003ctd\u003e19:37\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e14\u003c\/td\u003e\r\n\u003ctd\u003eBenzodiazepines: History, Mechanism \u0026amp; Misuse\u003c\/td\u003e\r\n\u003ctd\u003e33:06\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e15\u003c\/td\u003e\r\n\u003ctd\u003eBenzodiazepines: Withdrawal \u0026amp; Tapering\u003c\/td\u003e\r\n\u003ctd\u003e23:17\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e16\u003c\/td\u003e\r\n\u003ctd\u003eNicotine Use Disorder: NRT \u0026amp; Other Treatments\u003c\/td\u003e\r\n\u003ctd\u003e17:35\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e17\u003c\/td\u003e\r\n\u003ctd\u003eCannabis Use Disorder: Prevalence \u0026amp; Treatments\u003c\/td\u003e\r\n\u003ctd\u003e27:56\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e18\u003c\/td\u003e\r\n\u003ctd\u003eConnection Between Cannabis Use \u0026amp; Mental Health Conditions\u003c\/td\u003e\r\n\u003ctd\u003e04:55\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e19\u003c\/td\u003e\r\n\u003ctd\u003eMedical Marijuana: Current Landscape\u003c\/td\u003e\r\n\u003ctd\u003e08:38\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003c\/tbody\u003e\r\n\u003c\/table\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e","brand":"Amboss","offers":[{"title":"Default Title","offer_id":42954704617570,"sku":"MED-AMB08516","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/University-of-Miami-Management-of-Alcohol-Substance-Use-Disorders-2025.webp?v=1779382798","url":"https:\/\/meducourse.com\/products\/university-of-miami-management-of-alcohol-substance-use-disorders-2025","provider":"Meducourse","version":"1.0","type":"link"}